Fact CheckerSign in

NCT07502729Not yet recruiting

Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding

Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension

Source: ClinicalTrials.gov · Last updated 31 Mar 2026

Brief summary (registry, in English)

This study aims to evaluate the impact of high-risk factors-such as elevated portal venous pressure, concurrent large extra-luminal vessels, portal vein thrombosis, and prominent portosystemic shunts-on the efficacy of endoscopic therapy. By comparing with interventional treatment, the goal is to optimize the clinical management protocol for esophageal and gastric varices, enhance the therapeutic outcomes of portal hypertension-related esophageal and gastric varices, and improve patient prognosis.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
1066 (estimated)
First submitted
17 Mar 2026
Start date
17 Mar 2026
Primary completion date
31 Dec 2026
Lead sponsor
Shanghai Zhongshan Hospital
NCT number
NCT07502729

What you commit to

  • Study type: Observational
  • Planned participants: 1066
  • From 17 Mar 2026 to the primary completion date, 31 Dec 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous history of liver transplantation
  • Concurrent severe life-threatening diseases involving the circulatory, hematological, or respiratory systems

Other illness

  • Imaging or gastroscopy findings indicated ulcers or other causes of gastrointestinal bleeding

Other

  • Difficulty in follow-up, or lack of essential medical history information, imaging data, or other necessary records

Who the study is looking for

  • Admitted due to gastrointestinal bleeding and clinically diagnosed with portal hypertension
  • Underwent imaging examinations and gastroscopy within one week after admission
  • Gastroscopy revealed the presence of esophageal and/or gastric varices
  • Age over 18 years

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.